With the advent of GLP-1 receptor agonist therapy, when (if ever) do you consider adding pioglitazone to patients' diabetes regimen?

Yes, I do still use pioglitazone which I believe is under used. I like to consider pioglitazone in patients who have central obesity with leaner legs/arms, ie who have a potential mild form of lipodystrophy, and who have hypertriglyceridemia, MASLD/MASH and insulin resistance. I find that these pati...